For: | Hellings J. Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials. World J Psychiatry 2023; 13(6): 262-277 [PMID: 37383284 DOI: 10.5498/wjp.v13.i6.262] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v13/i6/262.htm |
Number | Citing Articles |
1 |
Scott M. Myers, Thomas D. Challman. Capute and Accardo' s Neurodevelopmental Disabilities in Infancy and Childhood. 2025; : 589 doi: 10.1016/B978-0-12-824060-1.00038-9
|
2 |
Jacopo Lamanna, Jacopo Meldolesi. Autism Spectrum Disorder: Brain Areas Involved, Neurobiological Mechanisms, Diagnoses and Therapies. International Journal of Molecular Sciences 2024; 25(4): 2423 doi: 10.3390/ijms25042423
|
3 |
Manasi Tadas, Nitu Wankhede, Pranali Chandurkar, Nandkishor Kotagale, Milind Umekar, Raj Katariya, Akash Waghade, Dadasaheb Kokare, Brijesh Taksande. Postnatal propionic acid exposure disrupts hippocampal agmatine homeostasis leading to social deficits and cognitive impairment in autism spectrum disorder-like phenotype in rats. Pharmacology Biochemistry and Behavior 2025; 252: 174030 doi: 10.1016/j.pbb.2025.174030
|
4 |
Lei Qin, Haijiao Wang, Wenjing Ning, Mengmeng Cui, Qian Wang. New advances in the diagnosis and treatment of autism spectrum disorders. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-01916-2
|
5 |
Elena V. Valeeva, Dmitry O. Nikitin, Lubov S. Nikiforova, Irina I. Semina, Ildus I. Ahmetov. Effects of Pharmacological Treatment on Telomere Length and the Expression of Telomerase/Shelterin-Related Genes in Rat Models of Autism. Journal of Molecular Neuroscience 2025; 75(2) doi: 10.1007/s12031-025-02353-4
|
6 |
Rashya Kasaeiyan, Isa Multazam Noor, Elisabetta Burchi. A comprehensive narrative review on psychotherapies for patients with autism spectrum disorders. Mental Wellness 2024; 2(1) doi: 10.4081/mw.2024.18
|
7 |
Margaret Danielle Weiss, Peter T. Daniolos, Kevin Coughlin, Norah Mulvaney-Day, Benjamin Cook, Debra Rosenblum. A Scoping Review of the Intersectionality of Autism and Intellectual and Developmental Disability with Social Inequity on Diagnosis and Treatment of Youth. Journal of Child and Adolescent Psychopharmacology 2024; 34(7): 292 doi: 10.1089/cap.2023.0058
|
8 |
Katarzyna Smolińska, Aleksandra Szopa, Jan Sobczyński, Anna Serefko, Piotr Dobrowolski. Nutritional Quality Implications: Exploring the Impact of a Fatty Acid-Rich Diet on Central Nervous System Development. Nutrients 2024; 16(7): 1093 doi: 10.3390/nu16071093
|
9 |
Govind Kale, Veeranjaneyulu Addepalli, Sharvari Joshi. A snapshot on introspection of autism spectrum disorder. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09514-5
|
10 |
SJ Brand. A case of neurodivergence – the basics of autism spectrum disorder. South African General Practitioner 2023; 4(4): 150 doi: 10.36303/SAGP.0090
|
11 |
Jessica A. Hellings, Saras Chen Singh, Sham Singh, An-Lin Cheng. Minimally Verbal Individuals with Autism Spectrum Disorders/Intellectual Disability and Challenging Behaviors: Can Strategic Psychiatric Treatment Help?. Disabilities 2024; 4(2): 277 doi: 10.3390/disabilities4020018
|
12 |
Lien Wang, Erin A. Clark, Lynsey Hanratty, Kenneth S. Koblan, Andrew Foley, Nina Dedic, Linda J. Bristow. TAAR1 and 5-HT1B receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid. Pharmacology Biochemistry and Behavior 2024; 245: 173862 doi: 10.1016/j.pbb.2024.173862
|
13 |
Yunfeng Yu, Xinyu Yang, Gang Hu, Yuman Yin, Rong Yu. Causal effects of 731 immune cell phenotypes on autism spectrum disorder: a Mendelian randomization study. Frontiers in Psychiatry 2024; 15 doi: 10.3389/fpsyt.2024.1397006
|
14 |
Hélène Verdoux, Clélia Quiles, Jose de Leon. Clozapine for persons with neurodevelopmental disorders: a systematic review and expert recommendations for clinical practice. Expert Review of Clinical Pharmacology 2024; 17(10): 923 doi: 10.1080/17512433.2024.2410395
|